• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number RMT311415
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/22/2021
Type of Reportable Event Serious Injury
Event or Problem Description
The following was reported to gore: on (b)(6) 2012, the patient presented with an unspecified aortic aneurysm and underwent treatment utilizing a gore® excluder® aaa endoprosthesis.The procedure was completed without issue.The patient tolerated the procedure.On (b)(6) 2021, the patient underwent reintervention for revision of the previously placed gore® excluder® aaa endoprosthesis utilizing two gore® excluder® conformable aaa endoprosthesis with active control (cxt a/c) and a gore® viabahn® vbx balloon expandable endoprosthesis (vbx).The physician placed the two cxt a/c devices proximal and utilized the sandwich graft technique with the vbx device placed in the left renal artery.The patient tolerated the procedure.Further information has been requested.
 
Additional Manufacturer Narrative
H6: code 22- according to the gore® excluder® aaa endoprosthesis instructions for use, adverse events that may occur and / or require intervention or additional intraoperative procedure time include, but are not limited to, component migration and endoleak.H6: component code added h6: investigation conclusion 22 added - according to the gore® excluder® aaa endoprosthesis instructions for use, adverse events that may occur and / or require intervention or additional intraoperative procedure time include, but are not limited to, component migration and endoleak.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL PHOENIX 2 B/P
32470 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
liam schultz
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12351154
Report Number3007284313-2021-01554
Device Sequence Number5189795
Product Code MIH
UDI-Device Identifier00733132610754
UDI-Public00733132610754
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2012
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/31/2015
Device Model NumberRMT311415
Device Catalogue NumberRMT311415
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/22/2021
Supplement Date Received by Manufacturer07/22/2021
03/11/2022
Initial Report FDA Received Date08/20/2021
Supplement Report FDA Received Date01/04/2022
03/11/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured04/27/2012
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age87 YR
Patient SexMale
Patient Weight61 KG
-
-